MITF and melanoma: In focusing on TCA cycle metabolic intermediates, we found that several were elevated in the MITF‐low pseudo‐hypoxic IGR39 melanoma cells as well as in MITF‐depleted 501mel cells (Figure 6e; boxed metabolites in Figure 6b).